MTH1, A Phase I, Study on Tumors Inhibition, First in Human, First in Class
Clinical trial NCT03036228 · COMPLETED
Trial details
- NCT number
- NCT03036228
- Sponsor
- Thomas Helleday Foundation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-14
- Primary completion
- 2024-12-17
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.